The Readout Loud 336: Pharma's big patent cliff, more obesity fundraising, and a failed ALS study
11 snips
Jan 9, 2025 The podcast delves into how pharmaceutical companies are grappling with a looming patent cliff, impacting their strategies and investments. It discusses new FDA guidance on obesity drug development, raising concerns for certain companies. A failed ALS study from Google's Calico adds intrigue to the conversation. The rise of obesity startups, especially after significant funding rounds, is also highlighted. Personal resolutions and the challenges of bio innovation wrap up the engaging dialogue.
AI Snips
Chapters
Transcript
Episode notes
Adam's Resolutions
- Adam Feuerstein's New Year's resolution was to learn guitar, then ukulele.
- Both were thwarted by a broken arm, then a broken elbow.
Watercolor Painting
- This year, Adam is trying watercolor painting.
- He finds it relaxing and a good way to get off screens.
New FDA Guidance
- The FDA issued new guidance on drug development, including one for obesity drugs.
- This is the first update since 2007.